ESR1 and breast cancer: However, the Sjögren cohort had a significantly higher risk of breast cancer occurring in overlapping sites (HR: 3.343, 95% CI: 1.315–8.498) and estrogen receptor positivity (HR: 1.860, 95% CI: 1.031–3.353) among the white population.